Bio Impact Capital LLC Akero Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 460,617 shares of AKRO stock, worth $20.6 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
460,617
Previous 392,544
17.34%
Holding current value
$20.6 Million
Previous $11.3 Million
13.78%
% of portfolio
1.92%
Previous 1.76%
Shares
4 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$330 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$307 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$270 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$250 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$234 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.08B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...